Sugiyama Y - Search Results

1

Expression and regulation of breast cancer resistance protein and multidrug resistance associated protein 2 in BALB/c mice.

Han Y, Sugiyama Y. Han Y, et al. Among authors: sugiyama y. Biol Pharm Bull. 2006 May;29(5):1032-5. doi: 10.1248/bpb.29.1032. Biol Pharm Bull. 2006. PMID: 16651740

2

Significance of binding to Na,K-ATPase in the tissue distribution of ouabain in guinea pigs.

Harashima H, Mamiya M, Yamazaki M, Sugiyama Y, Sawada Y, Iga T, Hanano M. Harashima H, et al. Among authors: sugiyama y. Pharm Res. 1992 Apr;9(4):474-9. doi: 10.1023/a:1015832127969. Pharm Res. 1992. PMID: 1323099

3

Kinetic modeling of ouabain tissue distribution based on slow and saturable binding to Na,K-ATPase.

Harashima H, Mamiya M, Yamazaki M, Sawada Y, Iga T, Hanano M, Sugiyama Y. Harashima H, et al. Among authors: sugiyama y. Pharm Res. 1992 Dec;9(12):1607-11. doi: 10.1023/a:1015820610048. Pharm Res. 1992. PMID: 1336859

4

Kinetic analysis of hepatobiliary transport of vincristine in perfused rat liver. Possible roles of P-glycoprotein in biliary excretion of vincristine.

Watanabe T, Miyauchi S, Sawada Y, Iga T, Hanano M, Inaba M, Sugiyama Y. Watanabe T, et al. Among authors: sugiyama y. J Hepatol. 1992 Sep;16(1-2):77-88. doi: 10.1016/s0168-8278(05)80098-4. J Hepatol. 1992. PMID: 1362433

5

Studies on cerebral protective agents. I. Novel 4-arylpyrimidine derivatives with anti-anoxic and anti-lipid peroxidation activities.

Kuno A, Sugiyama Y, Katsuta K, Kamitani T, Takasugi H. Kuno A, et al. Among authors: sugiyama y. Chem Pharm Bull (Tokyo). 1992 Jun;40(6):1452-61. doi: 10.1248/cpb.40.1452. Chem Pharm Bull (Tokyo). 1992. PMID: 1394663

6

Correlation between the inhibitory effects of basic drugs on the uptake of cardiac glycosides and taurocholate by isolated rat hepatocytes.

Okudaira K, Yamazaki M, Sawada Y, Sugiyama Y, Iga T, Hanano M. Okudaira K, et al. Among authors: sugiyama y. Pharm Res. 1992 Sep;9(9):1152-6. doi: 10.1023/a:1015895520584. Pharm Res. 1992. PMID: 1409396

7

Studies on cerebral protective agents. II. Novel 4-arylpyrimidine derivatives with anti-anoxic and anti-lipid peroxidation activities. (2).

Kuno A, Sugiyama Y, Katsuta K, Sakai H, Takasugi H. Kuno A, et al. Among authors: sugiyama y. Chem Pharm Bull (Tokyo). 1992 Sep;40(9):2423-31. doi: 10.1248/cpb.40.2423. Chem Pharm Bull (Tokyo). 1992. PMID: 1446365

8

Localization of binding sites for epidermal growth factor (EGF) in rat kidney: evidence for the existence of low affinity EGF binding sites on the brush border membrane.

Kim DC, Hanano M, Kanai Y, Ohnuma N, Sugiyama Y. Kim DC, et al. Among authors: sugiyama y. Pharm Res. 1992 Nov;9(11):1394-401. doi: 10.1023/a:1015846526461. Pharm Res. 1992. PMID: 1475224

9

Renal tubular handling of p-aminohippurate and epidermal growth factor (EGF) in filtering and nonfiltering perfused rat kidneys.

Kim DC, Sugiyama Y, Sawada Y, Hanano M. Kim DC, et al. Among authors: sugiyama y. Pharm Res. 1992 Feb;9(2):271-5. doi: 10.1023/a:1018957911614. Pharm Res. 1992. PMID: 1553353

10

Localization of epidermal growth factor (EGF) binding sites on antiluminal plasma membrane of rat kidney: autoradiographic study using nonfiltering perfused rat kidney.

Kim DC, Sugiyama Y, Kanai Y, Ohnuma N, Hanano M. Kim DC, et al. Among authors: sugiyama y. Pharm Res. 1992 Jan;9(1):40-4. doi: 10.1023/a:1018923609371. Pharm Res. 1992. PMID: 1589408

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results